CHINA HEALTH GRP HD-10 (VNL1) — Working Capital to Net Assets Ratio
CHINA HEALTH GRP HD-10 (VNL1) has a Working Capital to Net Assets ratio of 89.8% as of June 2025. Working capital of €70.40 Million (current assets of €102.00 Million minus current liabilities of €31.60 Million) is measured against net assets of €78.42 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. See VNL1 FCF to total liabilities ratio to measure the company's free cash flow as a share of total liabilities.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
CHINA HEALTH GRP HD-10 Working Capital to Net Assets (2021–2024)
This chart shows how CHINA HEALTH GRP HD-10's Working Capital to Net Assets ratio has evolved across 4 annual periods from 2021 to 2024. As of June 2025, the ratio stands at 89.8%, reflecting working capital of €70.40 Million against net assets of €78.42 Million EUR. See CHINA HEALTH GRP HD-10 defensive interval ratio to measure how many days the company can operate on defensive assets alone.
Annual Working Capital to Net Assets for CHINA HEALTH GRP HD-10 (2021–2024)
The table below presents the year-by-year Working Capital to Net Assets ratio for CHINA HEALTH GRP HD-10 from 2021 to 2024, covering 4 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For live market cap and the full company profile, see VNL1 company net worth.
| Year | WC/NA Ratio | Working Capital (EUR) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2024 | 88.1% | €61.39 Million | €69.72 Million | €92.64 Million | €31.24 Million | ▼ -3.4 pp |
| 2023 | 91.5% | €77.01 Million | €84.18 Million | €112.18 Million | €35.17 Million | ▼ -7.5 pp |
| 2022 | 99.0% | €140.48 Million | €141.88 Million | €177.23 Million | €36.74 Million | ▲ +0.0 pp |
| 2021 | 99.0% | €154.02 Million | €155.57 Million | €192.78 Million | €38.75 Million | — |